Betahistine for Meniere's disease
BMJ
.
2016 Jan 21:352:i46.
doi: 10.1136/bmj.i46.
Authors
Jonny Harcourt
1
,
Stefano Cosentino
2
Affiliations
1
Charing Cross Hospital, London W6 8RF, UK.
2
MRC Cognition and Brain Sciences Unit, Cambridge, UK Meniere's Society, Dorking, UK.
PMID:
26794224
DOI:
10.1136/bmj.i46
No abstract available
Publication types
Editorial
MeSH terms
Betahistine / therapeutic use*
Humans
Meniere Disease / drug therapy*
Vasodilator Agents / therapeutic use*
Substances
Vasodilator Agents
Betahistine